Dr. Reddy's Laboratories tanks 5 per cent on USFDA observations Dr. Reddy's Laboratories tanks 5 per cent on USFDA observations Gayathri Udyawar / Wednesday, October 31, 2018 0 1384 Article rating: 4.0 The stock of pharma major Dr. Reddy's Laboratories was under pressure in early morning trade on Wednesday as it reacted to the news of USFDA's observations issued for its Duvvada unit on Tuesday. Read more
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Wednesday, October 31, 2018 0 777 Article rating: 5.0 Overall volumes in futures & options currently stand at 1.33 crore contracts with a turnover of Rs. 7,19,557.92 crore. Read more
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Wednesday, October 31, 2018 0 1039 Article rating: 5.0 Overall volumes in futures & options currently stand at 1.33 crore contracts with a turnover of Rs. 7,19,557.92 crore. Read more
IRB Infra reports 20 per cent YoY revenue growth for Q2FY19 IRB Infra reports 20 per cent YoY revenue growth for Q2FY19 Pratik Shastri / Wednesday, October 31, 2018 0 3113 Article rating: 5.0 IRB Infrastructure Developers Limited Ltd. reported its results for the quarter ended September 30, 2018. IRB Infrastructure Developers Limited consolidated revenue for the quarter came in at Rs. 1485.43 crore, registering an increase of 19.6% YoY. Read more
Cholamandalam reports 43 per cent PAT growth, but asset quality worsens Cholamandalam reports 43 per cent PAT growth, but asset quality worsens Amir Shaikh / Tuesday, October 30, 2018 0 2187 Article rating: 3.0 The company’s Q2FY19 net profit grew by almost 43 per cent to Rs. 305 crore over the corresponding quarter of last year, while its total income during the period surged to Rs 1676 crore, which represented a growth of 24 per cent YoY. Read more